Literature DB >> 7658605

Are clinical signs accurate indicators of the cause of central venous catheter occlusion?

L C Stephens1, W D Haire, G D Kotulak.   

Abstract

BACKGROUND: Two hundred dysfunctional central venous catheters used for total parenteral nutrition and administration of cancer chemotherapy were radiographically examined in order to objectively identify thrombotic occlusions as the cause of catheter dysfunction.
METHODS: Outcomes of radiographic dye injections were compared with factors such as the inability to aspirate blood or to infuse fluids, catheter type, and duration of catheter placement.
RESULTS: Catheter type and duration of placement were not significant factors for predicting the type of dysfunction. Failure to withdraw blood was associated with 96% of the thrombosed catheters; this was also associated with 65% of the catheters with nonthrombotic dysfunctions. Once the cause of catheter occlusion was correctly identified, 90% of the catheters were restored to normal function.
CONCLUSIONS: Inability to withdraw blood from a catheter does not necessarily mean it is occluded by thrombus. Mechanical complications account for a significant portion of dysfunctional catheters.

Entities:  

Mesh:

Year:  1995        PMID: 7658605     DOI: 10.1177/014860719501900175

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  11 in total

Review 1.  Complications of long-term home total parenteral nutrition: their identification, prevention and treatment.

Authors:  A L Buchman
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 2.  Specific topics and complications of parenteral nutrition.

Authors:  Eduardo E Montalvo-Jave; José L Zarraga; Michael G Sarr
Journal:  Langenbecks Arch Surg       Date:  2007-01-13       Impact factor: 3.445

3.  [Complications of venous port systems : Radiological diagnostics and minimally invasive therapy].

Authors:  N Rathmann; D Hausmann; M Kostrzewa; M Keese; S Diehl; S Schönberg; M Sadick
Journal:  Radiologe       Date:  2011-05       Impact factor: 0.635

Review 4.  Thrombolytic therapy for central venous catheter occlusion.

Authors:  Jacquelyn L Baskin; Ulrike Reiss; Judith A Wilimas; Monika L Metzger; Raul C Ribeiro; Ching-Hon Pui; Scott C Howard
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

Review 5.  Interventions for restoring patency of occluded central venous catheter lumens.

Authors:  Clare van Miert; Rebecca Hill; Leanne Jones
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

6.  Diagnostic accuracy of the Catheter Injection and Aspiration (CINAS) classification for assessing the function of totally implantable venous access devices.

Authors:  G A Goossens; Y De Waele; M Jérôme; S Fieuws; C Janssens; M Stas; P Moons
Journal:  Support Care Cancer       Date:  2015-07-26       Impact factor: 3.603

Review 7.  Management of occlusion and thrombosis associated with long-term indwelling central venous catheters.

Authors:  Jacquelyn L Baskin; Ching-Hon Pui; Ulrike Reiss; Judith A Wilimas; Monika L Metzger; Raul C Ribeiro; Scott C Howard
Journal:  Lancet       Date:  2009-07-11       Impact factor: 79.321

8.  Enoxaparin treatment of spontaneous deep vein thrombosis in a chronically catheterized rhesus macaque (Macaca mulatta).

Authors:  Asheley B Wathen; Daniel D Myers; Paul Zajkowski; Graham Flory; F Claire Hankenson
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-09       Impact factor: 1.232

9.  Minimally Invasive Monitoring of Chronic Central Venous Catheter Patency in Mice Using Digital Subtraction Angiography (DSA).

Authors:  Giovanna Figueiredo; Teresa Fiebig; Stefanie Kirschner; Omid Nikoubashman; Lisa Kabelitz; Ahmed Othman; Andrea Nonn; Martin Kramer; Marc A Brockmann
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

10.  Comparison of hospital length of stay, costs, and readmissions of alteplase versus catheter replacement among patients with occluded central venous catheters.

Authors:  Frank R Ernst; Er Chen; Craig Lipkin; Darren Tayama; Alpesh N Amin
Journal:  J Hosp Med       Date:  2014-05-14       Impact factor: 2.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.